Comparison of in-vitro pharmacodynamics of once and twice daily ciprofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 5, 1999, Pages 661-667

  Bowker, K E ^a,b   Wootton, M ^a,b   Rogers, C A ^a,b   Lewis, R ^c   Holt, H A ^a,b   MacGowan, A P ^a,b  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

AREA UNDER THE CURVE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MODEL; MULTIPLE REGRESSION; PHARMACODYNAMICS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BACTERIA; BACTERIAL INFECTIONS; CIPROFLOXACIN; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032760248     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.5.661     Document Type: Article

References (18)

1. MacGowan, A. P. & Bowker, K. E. (1997). Pharmacodynamics of antimicrobial agents and rationale for their dosing. Journal of Chemotherapy 9, Suppl. 1, 64-73.
2. MacKenzie, F. M. & Gould, I. M. (1993). The post-antibiotic effect. Journal of Antimicrobial Chemotherapy 32, 519-37.
3. Leggett, J. E., Ebert, S., Fantin, B. & Craig, W. (1990). Comparative dose-effect relations at several dosing intervals for β lactam, aminoglycoside and quinolone antibiotics against Gram-negative bacilli in murine thigh-infection and pneumonitis models. Scandinavian Journal of Infectious Diseases 74, Suppl., 179-84.
4. Fantin, B., Legett, J., Ebert, S. & Craig, W. A. (1991). Correlation between in vitro and in vivo activity of antimicrobial agents against Gram-negative bacilli in a murine infection model. Antimicrobial Agents and Chemotherapy 35, 1413-22.
5. Roosendaal, R., Bakker-Woudenberg, I. A., van den Berghe-van Raffe, M., Vink-van den Berg, J. C. & Michel, B. M. F. (1989). Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae, pneumonia and septicemia in leukopenic rats. European Journal of Clinical Microbiology and Infectious Diseases 8, 878-87.
6. Drusano, G. L., Johnson, D. E., Rosen, M. & Standiford, H. C. (1993). Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy 37, 483-90.
7. Sullivan, M. C., Cooper, B. W., Nightingale, C. H., Quintiliani, R. & Lawlor, M. T. (1993). Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrobial Agents and Chemotherapy 37, 234-9.
8. Madaras-Kelly, K. J., Ostergaard, B. E., Horde, L. B. & Rotshafer, J. C. (1996). Twenty-four-hour area under the concentration-time-curve/MIC ratio as a generic predictor of fluroquinolone antimicrobial effect using three strains of Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy 40, 627-32.
9. Blaser, J., Stone, B. B., Groner M. C. & Zinner, S. H. (1987). Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy 31, 1054-60.
10. Firsov, A. A., Shevchenko, A. A., Vostrov, S. N. & Zinner, S. H. (1998). Inter and intra quinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept. Antimicrobial Agents and Chemotherapy 42, 659-65.
11. Forrest, A., Nix, D. E., Ballow, C. H., Gross, T. F., Birmingham, M. C. & Schentag, J. J. (1993). Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37, 1073-81.
12. Madaras-Kelly, K. J., Larsson, A. J. & Rotschafer, J. C. (1996). A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 37, 703-10.
13. Gau, W., Ploschke, H. J., Schmidt, K. & Weber, B. (1985). Determination of ciprofloxacin in biological fluids by high performance liquid chromatography. Journal of Liquid Chromatography 8, 485-97.
14. Holt, H. A., Bywater, M. J. & Reeves, D. S. (1990). In-vitro activity of cefpodoxime against 1834 isolates from domicilary infections in 20 UK centres. Journal of Antimicrobial Chemotherapy 26, Suppl. E, 7-12.
15. Forrest, A., Chodosh, S., Amantea, M. A., Collins, D. A. & Schentag, J. J. (1997). Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 40, Suppl. A, 45-57
16. Kang, S. A., Rybak, M. J., McGrath, B., Kaatz, G. W. & Seo, S. M. (1994). Pharmacodynamics of levofloxacin, ofloxacin and ciprofloxacin alone and in combination with rifampin against methicillin susceptible and resistant Staphylococcus aureus in an in vitro infection model. Antimicrobial Agents and Chemotherapy 38, 2702-9.
17. Preston, S. L., Drusano, G. L., Berman, A. L., Fowler, C. L., Chow, A. T., Dornseif, B. et al. (1998). Pharmacodynamics of levofloxacin: A new paradigm for early clinical trials. JAMA 279, 125-9
18. Hyatt, J. M., Nix, D. E. & Schentag, J. J. (1994). Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus and Pseudomonas aeruginosa for which MICs are similar. Antimicrobial Agents and Chemotherapy 38, 2730-7.